The cancers with better OS curves for MXD3 body hypermethylated expression were as follows: LGG (Figure 7A, p < 0.001), LIHC (Figure 7B, p = 0.048), KIRC (Figure 7C, p < 0.001), LAML (Figure 7G, p = 0.009), UVM (Figure 7I, p < 0.001), BLCA (Figure 7H, p = 0.008), CESC (Figure 7E, p = 0.002), BRCA (Figure 7F, p = 0.003), and ESCA (Figure 7D, p = 0.002). This evidence concerns the gene MXD3 and cancer.